Skip to main content
CDC Website

Physicians

Estimates of New HIV Infections in the United States, 2006 - 2009

This information sheet presents new estimates of the annual number of new HIV infections (HIV incidence) in the United States released by CDC in August 2011. The estimates, for 2006 through 2009, are the first multi-year estimates using CDC’s national HIV incidence surveillance methodology, which is based on direct measurement of new HIV infections using a laboratory test (the BED HIV-1 Capture Enzyme Immunoassay) that can classify new diagnoses as either recent or long-standing HIV infections.

Recommendations on the Use of Quadrivalent Human Papillomavirus Vaccine in Males — Advisory Committee on Immunization Practices (ACIP), 2011

On October 25, 2011, the Advisory Committee on Immunization Practices (ACIP) recommended routine use of quadrivalent human papillomavirus (HPV) vaccine (HPV4; Gardasil, Merck & Co. Inc.) in males aged 11 or 12 years. ACIP also recommended vaccination with HPV4 for males aged 13 through 21 years who have not been vaccinated previously or who have not completed the 3-dose series; males aged 22 through 26 years may be vaccinated. These recommendations replace the October 2009 ACIP guidance that HPV4 may be given to males aged 9 through 26 years.

MMWR: Vital Signs: HIV Infection, Testing, and Risk Behaviors Among Youths - United States

In this report, the CDC used the National HIV Surveillance System data to estimate among youths, prevalence rates of diagnosed HIV infection in 2009 and the number of new infections in 2010. CDC used the 2009 and 2010 Youth Risk Behavior Surveillance System for 9th -12th grade students and the 2010 National Health Interview Survey for persons 18-24 years. Prevalence of diagnosed HIV was 69.5 per 100,000 youths at the end of 2009. Youth accounted for 12,200 (25.7 percent) new HIV infections in 2010.

Treatment of Multidrug-Resistant Tuberculosis (MDR-TB)

This MDR TB online course exists as a free self-learning online tool in allowing physicians worldwide to learn and test their knowledge of MDR TB. It is accredited by the South African Medical Association and the Norwegian Medical Association. The course contains seven modules and covers etiology and pathogenesis of TB, diagnosis and treatment, special situations, patient-physician communication, treatment adherence, and TB infection and control. A PDF version of the course is available in French, Spanish, Mandarin Chinese, and Azeri.

Adverse Events of Antiretroviral Drugs

This internet electronic file discusses side effects of antiretroviral therapy for persons with HIV. The file provides information in table form on the most common adverse events for each of the five types of antiretroviral drugs.

2012 HIV Sourcebook for the Primary Care Provider

This monograph is a sourcebook that provides information about HIV infection for professionals who work in today’s health care system. It is meant be a convenient reference for some of the most common issues encountered in daily practice. It contains an outline of basic HIV patient care, and a list of resources that can be accessed locally. It presents guidelines and recommendations related to antiretroviral therapy (ART), treatment of opportunistic diseases, HIV testing and counseling, prevention of perinatal transmission, and post-exposure prophylaxis.

Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV Transmission in the United States

These guidelines present health care providers with information for discussion with HIV-infected pregnant women to enable the patient/provider team to make informed decisions regarding the use of antiretroviral drugs during pregnancy and use of elective cesarean delivery to reduce perinatal HIV transmission. The recommendations are accompanied by discussion of various circumstances that commonly occur in clinical practice and the factors influencing treatment considerations.

Was this page helpful? Give Feedback